Osang Healthcare Co.,Ltd (KOSDAQ:036220)
5,570.00
-110.00 (-1.94%)
Oct 23, 2026, 3:30 PM KST
Osang Healthcare Co.,Ltd Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 96,478 | 128,629 | 80,488 | 355,847 | 193,893 | 132,327 |
Revenue Growth | -15.35% | 59.81% | -77.38% | 83.53% | 46.53% | -48.70% |
Gross Profit Gross Profit Growth | 34,607 | 57,145 | 25,570 | 221,108 | 98,033 | 47,617 |
Operating Income Operating Income Growth | -20,521 | 2,427 | -24,566 | 142,339 | 49,255 | -7,106 |
Net Income Net Income Growth | -8,457 | 3,109 | -11,364 | 116,436 | 40,647 | 1,460 |
Earnings Per Share EPS Growth | -615.33 | 226.00 | -837.42 | 8921.00 | 3168.00 | 118.75 |
EPS Growth | - | - | - | 181.60% | 2567.89% | -98.76% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Europe Europe Growth | 23,808 | 25,101 | 24,590 | 20,558 | 28,411 | 38,614 |
Other Other Growth | 12,313 | 16,159 | 7,913 | 5,417 | 5,146 | 5,337 |
Korea Korea Growth | 13,656 | 12,636 | 16,013 | 17,797 | 89,333 | 23,000 |
South America South America Growth | 10,893 | 7,195 | 13,447 | 8,246 | 15,638 | 28,383 |
North America North America Growth | 24,311 | 54,140 | 6,533 | 292,707 | 39,217 | 16,818 |
Asia Asia Growth | 11,496 | 13,398 | 11,993 | 11,122 | 16,148 | 20,175 |
Total Total Growth | 96,478 | 128,629 | 80,488 | 355,847 | 193,893 | 132,327 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 44,095 | 41,817 | 10,412 | 143,734 | 61,140 | 47,183 |
Total Debt Total Debt Growth | 45,045 | 44,306 | 940.33 | 697.8 | 711.81 | 598.89 |
Net Cash (Debt) Net Cash Growth | -949.8 | -2,488 | 9,471 | 143,036 | 60,428 | 46,584 |
Net Cash Growth | - | - | -93.38% | 136.71% | 29.72% | -30.61% |
Net Cash Per Share Net Cash Per Share Growth | -69.07 | -181.08 | 697.93 | 10958.90 | 4707.82 | 3787.67 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 21,990 | 6,213 | -38,767 | 152,596 | 42,353 | 10,807 |
Capital Expenditures CapEx Growth | -14,792 | -16,094 | -27,810 | -35,703 | -11,702 | -9,040 |
Free Cash Flow Free Cash Flow Growth | 7,198 | -9,881 | -66,577 | 116,893 | 30,651 | 1,768 |
Free Cash Flow Growth | - | - | - | 281.36% | 1634.00% | -98.11% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.87% | 44.43% | 31.77% | 62.14% | 50.56% | 35.98% |
Operating Margin | -21.27% | 1.89% | -30.52% | 40.00% | 25.40% | -5.37% |
Pretax Margin | -10.72% | 1.97% | -28.64% | 42.84% | 26.74% | 0.03% |
Profit Margin | -8.77% | 2.42% | -14.12% | 32.72% | 20.96% | 1.10% |
FCF Margin | 7.46% | -7.68% | -82.72% | 32.85% | 15.81% | 1.34% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 200.000 | 200.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 3.59% | 1.69% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 52.37 | - | - | - | - |
PS Ratio | 0.78 | 1.27 | 1.94 | - | - | - |